Threshold Pharmaceuticals, Inc., based in South San Francisco,
California, is a research-driven biotechnology company dedicated to the discovery and development of tumor targeted therapies to improve the lives of patients with cancer.
- November 15, 2016
- Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016
- October 25, 2016
- Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting System in the Development Program for Evofosfamide
- September 29, 2016
- Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities